Plain-English translation of NCT07189403 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new experimental drug called in people with two types of advanced cancer: adrenocortical carcinoma (a rare cancer of the adrenal gland) and metastatic castration-resistant prostate cancer (prostate cancer that has spread and stopped responding to hormone therapy). Researchers are still figuring out the safest and most effective dose of this medication, and whether it can help people with these cancers.
Both of these cancers are serious and have limited treatment options, especially once they stop responding to standard therapies. This trial exists to explore whether the new treatment could offer hope to patients who have run out of other options.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive as your study medication, likely as an injection or infusion based on the early-stage nature of this trial. You would attend regular study visits where your doctors monitor your health, check how well the medication is working, and watch for any side effects through blood tests and imaging scans. The study is still in the early phase, so your dose may change as researchers determine the safest level.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States
France